Hepatocyte transplantation is a promising alternative to orthotopic liver transplantation, however, the fate of transplanted hepatocytes is not well defined. 99mTc-galactosyl-serum albumin (99mTc-GSA) is a clinical scintigraphic agent which is specifically taken up by the hepatocyte asialoglycoprotein receptor (ASGPR).
Aims:
To investigate labeling of fresh and cryopreserved human hepatocytes and fresh rat hepatocytes in vitro using 99mTc-GSA
Methods:
Human and rat hepatocytes were isolated from liver tissue by collagenase perfusion. The ASGPR were characterized using immunohistochemistry and RT-PCR. Hepatocytes were incubated with 99mTc-GSA in suspension at 4°C and 37°C. Cell viability and function was determined using cell mitochondrial dehydrogenase (MTS) and sulphorhodamine B (SRB) assays.
Results:
Fresh and cryopreserved human hepatocytes expressed the ASGPR. Incubation of hepatocytes in suspension with 99mTc-GSA reduced the viability of hepatocytes, but this was similar to unlabeled control cells. Greater loss of viability was seen on incubation at 37°C compared to 4°C, but there was a significantly greater uptake of 99mTc-GSA at the physiological temperature (6.6 ± SE 0.6-fold increase, p<0.05) consistent with ASGPR-mediated endocytosis. MTS and SRB assays were not significantly affected by labeling with 99mTc-GSA in all three cell types. A mean of 18.5% of the radioactivity was released over 120 min when 99mTc-GSA - labeled hepatocytes were shaken in vitro at 37°C.
Conclusions:
Human and rat hepatocytes can be labeled with 99mTc-GSA, which may have potential application for in vivo imaging after hepatocyte transplantation.
FisherR.A., StromS.C.. Human hepatocyte transplantation: worldwide results.Transplantation.2006; 82: 441–449.
3.
SmetsF., NajimiM., SokalE.M.. Cell transplantation in the treatment of liver diseases.Pediatr Transplant.2008; 12: 6–13.
4.
DhawanA., PuppiJ., HughesR.D., MitryR.R.. Human hepatocyte transplantation: current experience and future challenges.Nat Rev Gastroenterol Hepatol.2010; 7: 288–298.
5.
DhawanA., MitryR.R., HughesR.D.Hepatocyte transplantation for inherited factor VII deficiency.Transplantation.2004; 78: 1812–1814.
6.
PuppiJ., TanN., MitryR.R.Hepatocyte transplantation followed by auxiliary liver transplantation – a novel treatment for ornithine transcarbamylase deficiency.Am J Transplant.2008; 8: 452–457.
7.
StromS.C., ChowdhuryJ.R., FoxI.J.. Hepatocyte transplantation for the treatment of human disease.Semin Liver Dis.1999; 19: 39–48.
8.
QuagliaA., LehecS.C., HughesR.D.Liver after hepatocyte transplantation for liver-based metabolic disorders in children.Cell Transplant.2008; 17: 1403–1414.
9.
MasV.R., MalufD.G., ThompsonM., Ferreira-GonzalezA., FisherR.A.. Engraftment measurement in human liver tissue after liver cell transplantation by short tandem repeats analysis.Cell Transplant.2004; 13: 231–236.
10.
StéphenneX., NajimiM., SibilleC.Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency.Gastroenterology.2006; 130: 1317–1323.
11.
GuptaS., RajvanshiP., SokhiR.Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium.Hepatology.1999; 29: 509–519.
12.
KokudoN., VeraD.R., MakuuchiM.. Clinical application of TcGSA.Nucl Med Biol.2003; 30: 845–849.
13.
KudoM., VeraD.R., StadalnikR.C.Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin.Dig Dis Sci.1993; 38: 2183–2188.
YoshidaH., MamadaY., TaniaiN.Simultaneous evaluation of portal hemodynamics and liver function by scintiphotosplenoportography in pediatric recipients of living-donor liver transplants.Hepatogastroenterology.2009; 56: 819–823.
16.
KimS., JeongJ.M., HongM.K.Differential receptor targeting of liver cells using 99mTc-neoglycosylated human serum albumins.Arch Pharm Res.2008; 31: 60–66.
17.
WeigelP.H.. Endocytosis and function of the hepatic asialoglycoprotein receptor.Subcell Biochem.1993; 19: 125–161.
18.
CaseyC.A., LeeS.M., Aziz-SeibleR., McvickerB.L.. Impaired receptor-mediated endocytosis: its role in alcohol-induced apoptosis.J Gastroenterol Hepatol.2008; 23(Suppl 1): S46–S4.
LeeS.M., CaseyC.A., McVickerB.L.. Impact of asialoglycoprotein receptor deficiency on the development of liver injury.World J Gastroenterol.2009; 15: 1194–1200.
21.
PimstoneN.R., StadalnikR.C., VeraD.R., HutakD.P., TrudeauW.L.. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog.Hepatology.1994; 20: 917–923.
22.
StockertR.J.. The asialoglycoprotein receptor: relationships between structure, function, and expression.Physiol Rev.1995; 75: 591–609.
23.
MitryR.R., HughesR.D., AwM.M.Human hepatocyte isolation and relationship of cell viability to early graft function.Cell Transplant.2003; 12: 69–74.
24.
DienerB., UteschD., BeerN., DurkH., OeschF.. A method for the cryopreservation of liver parenchymal cells for studies of xenobiotics.Cryobiology.1993; 30: 116–127.
25.
TerryC., DhawanA., MitryR.R., LehecS.C., HughesR.D.. Optimization of the cryopreservation and thawing protocol for human hepatocytes for use in cell transplantation.Liver Transpl.2010; 16: 229–237.
26.
SteinbergP., FischerT., KiuliesS.Drug metabolizing capacity of cryopreserved human, rat, and mouse liver parenchymal cells in suspension.Drug Metab Dispos.1999; 27: 1415–1422.
27.
ReeseJ.A., ByardJ.L.. Isolation and culture of adult hepatocytes from liver biopsies.In Vitro.1981; 17: 935–940.
28.
WeigelP.H., YikJ.H.. Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors.Biochim Biophys Acta.2002; 1572: 341–363.
TerryC., MitryR.R., LehecS.C.The effects of cryopreservation on human hepatocytes obtained from different sources of liver tissue.Cell Transplant.2005; 14: 585–594.
31.
TerryC., DhawanA., MitryR.R., HughesR.D.. Cryopreservation of isolated human hepatocytes for transplantation: State of the art.Cryobiology.2006; 53: 149–159.
32.
GuptaS., VasaS.R., RajvanshiP.Analysis of hepatocyte distribution and survival in vascular beds with cells marked by 99mTC or endogenous dipeptidyl peptidase IV activity.Cell Transplant.1997; 6: 377–386.
33.
CostaD.C., EllP.J., CullumI.D., JarrittP.H.. The in vivo distribution of 99Tcm-HM-PAO in normal man.Nucl Med Commun.1986; 7: 647–658.
34.
ChengK., BentenD., BhargavaK.Hepatic targeting and biodistribution of human fetal liver stem/progenitor cells and adult hepatocytes in mice.Hepatology.2009; 50: 1194–1203.
35.
BohnenN.I., CharronM., ReyesJ.Use of indium-111-labeled hepatocytes to determine the biodistribution of transplanted hepatocytes through portal vein infusion.Clin Nucl Med.2000; 25: 447–450.
36.
PuppiJ., MitryR.R., ModoM.Use of a clinically approved iron oxide MRI contrast agent to label human hepatocytes.Cell Transplant.2011; 20: 963–975.
37.
TerryC., HughesR.D., MitryR.R., LehecS.C., DhawanA.. Cryopreservation-induced nonattachment of human hepatocytes: role of adhesion molecules.Cell Transplant.2007; 16: 639–647.
38.
KaiboriM., Ha-KawaS.K., UchidaY.Liver regeneration in donors evaluated by Tc-99m-GSA scintigraphy after living donor liver transplantation.Dig Dis Sci.2008; 53: 850–855.
39.
KwonA.H., MatsuiY., KaiboriM., Ha-KawaS.K.. Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection.Surgery.2006; 140: 379–386.
40.
KwonA.H., MatsuiY., KaiboriM., KamiyamaY.. Functional hepatic regeneration following hepatectomy using galactosyl-human serum albumin liver scintigraphy.Transplant Proc.2004; 36: 2257–2260.
41.
ShukeN., OkizakiA., KinoS.Functional mapping of regional liver asialoglycoprotein receptor amount from single blood sample and SPECT.J Nucl Med.2003; 44: 475–482.
